Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer
Go back to Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer| Cocrystal Pharma, Inc. (NASDAQ: COCP) | Delayed: 0.99 -0.02 (1.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.01 | 52 Week High | $0.92 | |||
| Open | $0.99 | 52 Week Low | $0.32 | |||
| Day High | $1.02 | P/E | N/A | |||
| Day Low | $0.99 | EPS | $-0.18 | |||
| Volume | 80,613 | |||||
